| Schedule of Reportable segments |
The following table presents selected financial information about
the Company’s reportable segments for the six months ended June 30, 2019.
| | |
CONSOLIDATED | |
HEALTH SUPPLEMENTS | |
CBD | |
CORPORATE |
| Revenue | |
| 298,313 | | |
| 298,313 | | |
| — | | |
| — | |
| Cost of Revenue | |
| 78,004 | | |
| 77,504 | | |
| 500 | | |
| — | |
| Long-lived Assets | |
| — | | |
| — | | |
| — | | |
| — | |
| Gain Before Income Tax | |
| 1,316,587 | | |
| (244,157 | ) | |
| 92,609 | | |
| 1,468,136 | |
| Identifiable Assets | |
| 3,079,493 | | |
| 2,882,733 | | |
| — | | |
| 196,760 | |
| Depreciation and Amortization | |
| 3,904 | | |
| 3,574 | | |
| — | | |
| 330 | |
The
following table presents selected financial information about the Company’s reportable segments for the three months ended
June 30, 2019.
| | |
CONSOLIDATED | |
HEALTH SUPPLEMENTS | |
CBD | |
CORPORATE |
| Revenue | |
| 201,040 | | |
| 201,040 | | |
| — | | |
| — | |
| Cost of Revenue | |
| 46,741 | | |
| 46,241 | | |
| — | | |
| — | |
| Long-lived Assets | |
| — | | |
| — | | |
| — | | |
| — | |
| Loss Before Income Tax | |
| (278,392 | ) | |
| (130,614 | ) | |
| (162 | ) | |
| (147,615 | ) |
| Identifiable Assets | |
| 3,079,493 | | |
| 2,882,733 | | |
| — | | |
| 196,760 | |
| Depreciation and Amortization | |
| 2,290 | | |
| 2,191 | | |
| — | | |
| 99 | |
|